AI in regulatory filings and trials: Annovis partners with Weave Bio; Cori Clinical raises $4M seed round
Annovis Bio is using Weave Bio's AI-based regulatory platform to prepare the NDA for buntanetap. Cori Clinical has raised a $4M seed round for its AI clinical trial platform.
Who is affected and how
- pharmaceuticals
- AI has also appeared in preparing regulatory documentation and organising trials.
Sources
- Annovis Bio Partners With Weave Bio's AI Regulatory Platform in Preparation of NDA for Buntanetapbiobuzz.io · Oct 10, 2026
- Annovis Announces Partnership with Weave Bio, AI Regulatoryglobenewswire.com · Oct 10, 2026
- Cori Clinical Raises $4M Seed Round Led By Breega For AI Clinical Trial Platformhttps://ascendants.in/ · Oct 7, 2026
- Cori Clinical Raises $4M Seed to Accelerate Drug Trials | InnotechInsiderinnotechinsider.com · Oct 7, 2026
Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.